HomeCompareARKAF vs ORCC

ARKAF vs ORCC: Dividend Comparison 2026

ARKAF yields 6.25% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ARKAF wins by $15.37M in total portfolio value
10 years
ARKAF
ARKAF
● Live price
6.25%
Share price
$65.28
Annual div
$4.08
5Y div CAGR
63.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15.40M
Annual income
$12,565,924.61
Full ARKAF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — ARKAF vs ORCC

📍 ARKAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodARKAFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ARKAF + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ARKAF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARKAF
Annual income on $10K today (after 15% tax)
$530.89/yr
After 10yr DRIP, annual income (after tax)
$10,681,035.92/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, ARKAF beats the other by $10,681,035.03/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARKAF + ORCC for your $10,000?

ARKAF: 50%ORCC: 50%
100% ORCC50/50100% ARKAF
Portfolio after 10yr
$7.71M
Annual income
$6,282,962.82/yr
Blended yield
81.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

ARKAF
No analyst data
Altman Z
1.7
Piotroski
7/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARKAF buys
0
ORCC buys
18
PoliticianChamberTickerTypeAmountDate
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-23
Trey Hollingsworth🏢 House$ORCC▲ Buy$250,001 - $500,0002022-06-16
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-14
Trey Hollingsworth🏢 House$ORCC▲ Buy$50,001 - $100,0002022-06-13
Trey Hollingsworth🏢 House$ORCC▲ Buy$50,001 - $100,0002022-06-10
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-09
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-08
Trey Hollingsworth🏢 House$ORCC▲ Buy$50,001 - $100,0002022-06-03
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-05-24
Trey Hollingsworth🏢 House$ORCC▲ Buy$100,001 - $250,0002022-05-20
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricARKAFORCC
Forward yield6.25%9.79%
Annual dividend / share$4.08$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR63.9%-50%
Portfolio after 10y$15.40M$21.4K
Annual income after 10y$12,565,924.61$1.04
Total dividends collected$15.13M$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: ARKAF vs ORCC ($10,000, DRIP)

YearARKAF PortfolioARKAF Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$11,724$1,023.67$11,190$489.61+$534.00ARKAF
2$14,383$1,838.31$12,229$256.01+$2.2KARKAF
3$18,844$3,454.54$13,216$130.74+$5.6KARKAF
4$27,096$6,932.96$14,207$66.02+$12.9KARKAF
5$44,263$15,270.27$15,234$33.17+$29.0KARKAF
6$85,571$38,210.04$16,317$16.62+$69.3KARKAF
7$204,713$113,151.61$17,468$8.32+$187.2KARKAF
8$633,684$414,641.32$18,695$4.16+$615.0KARKAF
9$2,644,095$1,966,052.75$20,006$2.08+$2.62MARKAF
10$15,395,106$12,565,924.61$21,407$1.04+$15.37MARKAF

ARKAF vs ORCC: Complete Analysis 2026

ARKAFStock

Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. The company operates through Adhesive Solutions, Advanced Materials, Coating Solutions, and Intermediates segments. It provides adhesive solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets. The company also offers advanced materials consisting of specialty polyamides and polyvinylidene fluoride; and performance additives, such as specialty surfactants and molecular sieves, organic peroxides, thiochemicals, and hydrogen peroxide for use in automotive and transportation, oil and gas, renewable energies, consumer goods, electronics, construction, coatings, animal nutrition, and water treatment sectors. In addition, it provides coating solutions comprising EU/US acrylics and coating resins; sartomer photocure resins and coatex rheology additives; decorative paints, industrial coatings, and adhesives; and solutions for applications in the paper, superabsorbents, water treatment and oil and gas extraction, and 3D printing and electronics industries. Further, the company offers fluorogases and acrylics; and industrial intermediate chemicals used in construction, refrigeration and air conditioning, automotive, coatings, and water treatment sectors. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France.

Full ARKAF Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this ARKAF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARKAF vs SCHDARKAF vs JEPIARKAF vs OARKAF vs KOARKAF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.